Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
Luo, Beibei, Li, Bo, Wang, Wenke, Liu, Xiangjuan, Liu, Xiaoman, Xia, Yanfei, Zhang, Cheng, Zhang, Yun, Zhang, Mingxiang, An, FengshuangVolume:
28
Language:
english
Journal:
Cardiovascular Drugs and Therapy
DOI:
10.1007/s10557-013-6498-1
Date:
February, 2014
File:
PDF, 1.06 MB
english, 2014